IL13 (Myc-DDK-tagged)-Human interleukin 13 (IL13)
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
Products
Il13 (Myc-DDK-tagged) - Mouse interleukin 13 (Il13)
| Type | Mouse Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Carrier-free (glycerol/BSA-free) IL13 mouse monoclonal antibody, clone OTI6D3 (formerly 6D3)
| Applications | WB |
| Reactivities | Human |
IL13 mouse monoclonal antibody, clone OTI6D3 (formerly 6D3)
| Applications | WB |
| Reactivities | Human |
IL13 mouse monoclonal antibody, clone OTI6D3 (formerly 6D3)
| Applications | WB |
| Reactivities | Human |
IL13 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
IL13 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
IL13 mouse monoclonal antibody, clone OTI6D3 (formerly 6D3), Biotinylated
| Applications | WB |
| Reactivities | Human |
IL13 mouse monoclonal antibody, clone OTI6D3 (formerly 6D3), HRP conjugated
| Applications | WB |
| Reactivities | Human |
IL13 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
Il13 - KN2.0, Mouse gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
Recombinant protein of secreted form of human interleukin 13 (IL13)
| Tag | N-His/DDK |
| Expression Host | HEK293T |
Transient overexpression lysate of interleukin 13 (IL13)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression of IL13 in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
IL13 CRISPRa kit - CRISPR gene activation of human interleukin 13
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
